Immunogenicity of three recombinant hepatitis B vaccines administered to students in three doses containing half the antigen amount routinely used for adult vaccination

Revista do Instituto de Medicina Tropical de Sao Paulo

Volumn 46, Issue 2, 2004, Pages 103-107

  Da Silveira Baldy, José Luís ^a   De Lima, Gerson Zanetta ^a   Morimoto, Helena Kaminami ^a   Reiche, Edna Maria Vissoci ^a   Matsuo, Tiemi ^a   De Mattos, Edlivia Dias ^b   Sudan, Luci Cristina Pulga ^b  

^a STATE UNIVERSITY OF LONDRINA   (Brazil)

^b UNIVERSIDADE NORTE DO PARANÁ   (Brazil)

Author keywords

Adverse effects; Immunogenicity; Recombinant hepatitis B vaccines

Indexed keywords

ANTIGEN; BUTANG; HEPATITIS B ANTIBODY; HEPAVAX GENE; RECOMBINANT HEPATITIS B VACCINE;

ADOLESCENT; ADULT; ANTIBODY TITER; ARTICLE; COMPARATIVE STUDY; DISEASE MARKER; DOSE RESPONSE; DRUG EFFICACY; FEMALE; HEPATITIS B; HUMAN; HUMAN EXPERIMENT; IMMUNOGENICITY; MALE; SEROCONVERSION; SIDE EFFECT; TREATMENT OUTCOME; VACCINATION;

EID: 2342562943     PISSN: 00364665     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0036-46652004000200009     Document Type: Article

References (10)

1. AMERICAN ACADEMY OF PEDIATRICS - Hepatitis B. In: PICKERING, L.K., ed. 2000 Red Book: report of the Committee on Infectious Diseases. 25. ed. Elk Grove Village, American Academy of Pediatrics, 2000. p. 294.
2. BRYAN, J.P.; CRAIG, P.G.; REYES, L. et al. - Randomized comparison of 5 and 10 microgram doses of two recombinant hepatitis B vaccines. Vaccine, 13: 978-982, 1995.
3. CATANIA, G.; Di CIOMMO, V. & CONCATO, C. - Vaccination against hepatitis B virus in children and adolescents in a pediatric hospital. Recent Progr. Med., 87: 271-274, 1996.
4. ELASHOFF, J.D. - nQuery Advisor® Version 2.0 User's Guide. Los Angeles, Dixon Associates, 1997.
5. FRANCIS, D.P.; HADLER, S.C.; THOMPSON, S.E. et al. - The prevention of hepatitis B with vaccine. Report from the Centers for Disease Control multi-center efficacy trial among homosexual men. Ann. intern. Med., 97: 362-366, 1982.
6. HADLER, S.C.; FRANCIS, D.P.; MAYNARD, J.E. et al. - Long-term immunogenicity and efficacy of hepatitis B vaccine in homosexual men. New Engl. J. Med., 315: 209-214, 1986.
7. LEROUX-ROELS, G.; ABRAHAM, B.; FOURNEAU, M.; De CLERCQ, N. & SAFARY, A. - A comparison of two commercial recombinant vaccines for hepatitis B in adolescents. Vaccine, 19: 937-942, 2000.
8. POOVORAWAN, Y.; PONGPUNLERT, W.; THEAMBOONLERS, A. et al. - Randomized, single-blind comparison of the immunogenicity and reactogenicity of 20 micrograms and 10 micrograms doses of hepatitis B vaccine in adolescents. Southeast Asian J. trop. Med. publ. Hlth., 24: 255-259, 1993.
9. SAS INSTITUTE INC. - SAS/STAT user's guide, version 6.4. ed. Cary, SAS Institute, 1989. v. 1.
10. SCHIFF, G.M.; SHERWOOD, J.R.; ZELDIS, J.B. & KRAUSE, D.S. - Comparative study of the immunogenicity and safety of two doses of recombinant hepatitis B vaccine in healthy adolescents. J. Adolesc. Hlth., 26: 12-17, 1995.